Astragalus

Common name: Huang qi

Botanical name: Astragalus membranaceus

Parts used and where grown

Astragalus is native to northern China and the elevated regions of the Chinese provinces, Yunnan and Sichuan. The portion of the plant used medicinally is the four- to seven-year-old dried root, collected in the spring. While over 2,000 types of astragalus exist worldwide, the Chinese version has been extensively tested, both chemically and pharmacologically.¹

Astragalus has been used in connection with the following conditions (refer to the individual health concern for complete information):

Science Ratings

Health Concerns

Common cold/sore throat

Systemic lupus erythematosus

Reliable and relatively consistent scientific data showing a substantial health benefit.
2Stars

Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
1Star

For a herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support and/or minimal health benefit.

Historical or traditional use (may or may not be supported by scientific studies)

Shen Nung, the founder of Chinese herbal medicine, classified astragalus as a superior herb in his classical treatise Shen Nung Pen Tsao Ching (circa A.D. 100). The Chinese name huang qi translates as “yellow leader,” referring to the yellow colour of the root and its status as one of the most important tonic herbs. Traditional Chinese Medicine used this herb for night sweats, deficiency of chi (e.g., fatigue, weakness, and loss of appetite), and diarrhoea.²

Active constituents

Astragalus contains numerous components, including flavonoids, polysaccharides, triterpene glycosides (e.g., astragalosides I–VII), amino acids, and trace minerals.³ Several preliminary clinical trials in China have suggested that astragalus can benefit immune function and improve survival in some people with cancer.⁴ Given the poor quality of these trials, it is difficult to know how useful astragalus really was. One Chinese trial also found that astragalus could decrease overactive immune function in people with systemic lupus erythematosus (SLE), an auto-immune disease.⁵ Further trials are needed, however, to know if astragalus is safe for people with SLE, or any other auto-immune disease.

A double-blind trial found that, in people undergoing dialysis for kidney failure, intravenous astragalus improved one facet of immune function compared to the immune function of untreated people.⁶ Further study is needed to determine if astragalus can help prevent infections in people undergoing dialysis. Early clinical trials in China suggest astragalus root might also benefit people with chronic viral hepatitis, though it may take one to two months to see results.⁷

In preliminary trials in China, astragalus has been used after people suffer heart attacks.⁸ More research is needed to determine whether astragalus is truly beneficial in this situation.

How much is usually taken?

Textbooks on Chinese herbs recommend taking 9–15 grams of the crude herb per day in decoction form.⁹ A decoction is made by boiling the root in water for a few minutes and then brewing the tea. Alternatively, 3–5 ml of tincture three times per day, are sometimes recommended.

Are there any side effects or interactions?

Astragalus has no known side effects when used as recommended.

At the time of writing, there were no well-known drug interactions with astragalus.

References
(To view, roll mouse over heading; to hide, click on heading)

1. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics, 2d ed. New York: John Wiley & Sons, 1996, 50–3.

2. Foster S, Yue CX. Herbal Emissaries: Bringing Chinese Herbs to the West. Rochester, VT: Healing Arts Press, 1992, 27–33.

3. Shu HY. Oriental Materia Medica: A Concise Guide. Palos Verdes, CA: Oriental Healing Arts Press, 1986, 521–3.

4. Klepser T, Nisly N. Astragalus as an adjunctive therapy in immunocompromised patients. Alt Med Alert 1999;Nov:125–8 [review].

5. Klepser T, Nisly N. Astragalus as an adjunctive therapy in immunocompromised patients. Alt Med Alert 1999;Nov:125–8 [review].

6. Qun L, Luo Q, Zhang ZY, et al. Effects of astragalus on IL-2/IL-2R system in patients with maintained hemodialysis. Clin Nephrol 1999;52:333–4 [letter].

7. Tang W, Eisenbrand G. Chinese Drugs of Plant Origin. Berlin: Springer Verlag, 1992, 1056.

8. Li SQ, Yuan RX, Gao H. Clinical observation on the treatment of ischemic heart disease with Astragalus membranaceus. Chung Kuo Chung His I Chieh Ho Tsa Chih 1995;15:77–80 [in Chinese].

9. Foster S. Herbs for Your Health. Loveland, CO: Interweave Press, 1996, 6–7.

Learn more about Healthnotes, the company.

Learn more about the authors of Healthnotes.

The information presented in Healthnotes is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or chemist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires March 2007.